Literature DB >> 34268706

Aetiology, diagnosis, and treatment of brachymetatarsia: a narrative review.

F Fusini1, M Alessandro2, A Rava2, Z Kristijan3, L Felli4, G Colò5.   

Abstract

Brachymetatarsia (BM), or hypoplastic metatarsal, is an abnormal shortening of one or more metatarsal bones with a female-to-male ratio of 10.53:1. Different causes are described in the literature, such as congenital, acquired, or iatrogenic, associated with different conditions and syndromes. Its presence may develop deformity and pain; however, often feet are pain free and the major worries of patients are cosmetics. Non-operative treatments aim to improve the comfort of metatarsal heads and the possible dorsal conflict through comfortable shoes or the use of specific orthotics. The surgical treatment is anything but straightforward, with "one-stage" or "two stage" techniques, the latter better called "by gradual distraction". One-stage procedures are more rapid techniques but have limited ability to restore the desired length due to neurovascular compromise caused by acute lengthening. Insufficient correction is also possible. On the contrary, by gradual distraction procedures allow gradual distraction lengthening of more than 1.5 cm, but require the use of an external fixator, with a higher risk of complications in more than about 50% of surgeries. The adjacent metatarsal shortening should be considered in combination with other techniques, to diminish the excessive lengthening. In each case, surgeries should be always decided on each patient's concerns, deformities, and clinical needs.
© 2021. Istituto Ortopedico Rizzoli.

Entities:  

Keywords:  Bone lengthening; Brachymetatarsia; Forefoot; Fourth; Metatarsal lengthening; Metatarsals

Mesh:

Year:  2021        PMID: 34268706     DOI: 10.1007/s12306-021-00720-z

Source DB:  PubMed          Journal:  Musculoskelet Surg        ISSN: 2035-5114


  37 in total

1.  Chevron bone graft procedure for the correction of brachymetatarsia.

Authors:  S A Alter; B Feinman; R G Rosen
Journal:  J Foot Ankle Surg       Date:  1995 Mar-Apr       Impact factor: 1.286

Review 2.  Brachymetatarsia: congenitally short third and fourth metatarsals treated by distraction lengthening--a case report and literature summary.

Authors:  J F Robinson; T J Ouzounian
Journal:  Foot Ankle Int       Date:  1998-10       Impact factor: 2.827

Review 3.  Literature Review on Brachymetatarsia.

Authors:  Antonio Córdoba-Fernández; Maria Luisa Vera-Gómez
Journal:  Orthop Nurs       Date:  2018 Sep/Oct       Impact factor: 0.913

4.  [Treatment options for brachymetatarsia].

Authors:  C Wingenfeld; D Arbab; M Abbara-Czardybon
Journal:  Orthopade       Date:  2013-01       Impact factor: 1.087

5.  Incidence, diagnosis and management of sacroiliitis after spinal surgery: a systematic review of the literature.

Authors:  G Colò; L Cavagnaro; M Alessio-Mazzola; A Zanirato; L Felli; M Formica
Journal:  Musculoskelet Surg       Date:  2019-05-07

6.  Treatment of brachymetatarsia by callus distraction (callotasis).

Authors:  T Kawashima; A Yamada; K Ueda; K Harii
Journal:  Ann Plast Surg       Date:  1994-02       Impact factor: 1.539

7.  Principles of ontogenesis of leg and foot in man.

Authors:  K V Hinrichsen; H J Jacob; M Jacob; B Brand-Saberi; B Christ; M Grim
Journal:  Ann Anat       Date:  1994-04       Impact factor: 2.698

8.  Congenital brachymetatarsia: three cases.

Authors:  L Ferrández; J Yubero; J Usabiaga; L Ramos
Journal:  Foot Ankle       Date:  1993 Nov-Dec

9.  Central metatarsal fractures: a review and current concepts.

Authors:  Elena Manuela Samaila; Alessandro Ditta; Stefano Negri; Massimiliano Leigheb; Gabriele Colò; Bruno Magnan
Journal:  Acta Biomed       Date:  2020-05-30

Review 10.  The efficacy of shoe modifications and foot orthoses in treating patients with hallux rigidus: a comprehensive review of literature.

Authors:  Gabriele Colò; Federico Fusini; Elena Manuela Samaila; Alessandro Rava; Lamberto Felli; Mattia Alessio-Mazzola; Bruno Magnan
Journal:  Acta Biomed       Date:  2020-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.